Limiting Respiratory Viral Infection by Targeting Antiviral and Immunological Functions of BST‐2/Tetherin: Knowledge and Gaps

por Berry, Kayla N., Kober, Daniel L., Su, Alvin, Brett, Tom J.
Publicado 2018

Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms

por Kober, Daniel L, Alexander-Brett, Jennifer M, Karch, Celeste M, Cruchaga, Carlos, Colonna, Marco, Holtzman, Michael J, Brett, Thomas J
Publicado 2016

Development of a mutant aerosolized ACE2 that neutralizes SARS-CoV-2 in vivo

por Kober, Daniel L., Caballero Van Dyke, Marley C., Eitson, Jennifer L., Boys, Ian N., McDougal, Matthew B., Rosenbaum, Daniel M., Schoggins, John W.
Publicado 2023

TREM-2 promotes macrophage survival and lung disease after respiratory viral infection

por Wu, Kangyun, Byers, Derek E., Jin, Xiaohua, Agapov, Eugene, Alexander-Brett, Jennifer, Patel, Anand C., Cella, Marina, Gilfilan, Susan, Colonna, Marco, Kober, Daniel L., Brett, Tom J., Holtzman, Michael J.
Publicado 2015